Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP)

3.40
Delayed Data
As of Feb 23
 +0.02 / +0.59%
Today’s Change
2.85
Today|||52-Week Range
9.40
-1.45%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Operating ActivitiesNet Income / Starting Line-10.9M-27.6M-48.1M-38.8M
 
 
 
 
 
Depreciation17.0K36.0K96.0K206.0K
 
 
 
 
 
Total Other Cash Flow1.8M3.7M4.5M3.4M
 
 
 
 
 
Funds From Operations-9.1M-23.9M-43.5M-35.2M
 
 
 
 
 
Funds From/For Other Operating Expenses-582.0K-1.0M-987.0K2.1M
 
 
 
 
 
Net Cash Flow - Operating Activities-8.5M-22.8M-42.5M-37.3M
 
 
 
 
 
 
InvestingIncrease In Investments0.000.00-28.6M0.00
 
 
Decrease In Investments0.000.004.7M45.0K
 
 
 
Capital Expenditures-15.0K-319.0K-118.0K-66.0K
 
 
 
 
 
Other Investing - Uses0.00-73.0K0.000.00
 
 
Other Investing - Sources0.000.000.0016.6M
 
 
Net Cash Flow Investing-15.0K-392.0K-24.2M16.6M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings280.0K0.000.000.00
 
 
Long Term Debt Reduction0.00-280.0K0.000.00
 
 
Net Proceeds Stock Sale10.0M47.8M47.7M20.5M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing4.6M5.7M0.000.00
 
 
 
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing15.0M53.2M47.7M20.5M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-1.0K-3.0K-4.0K-11.0K
 
 
 
 
 
 
Net Change In Cash6.4M30.0M-19.0M-223.0K